Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05176288
Title Avelumab, Palbociclib and Axitinib in Advanced RCC (APART)
Acronym APART
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradley A. McGregor
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field